Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed2
Other1

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT04667039Phase 3Unknown
Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis®
Age Related Macular Degeneration (ARMD)
StudychairStart date: 2022-03-20
NCT04671810Completed
Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria®
Paroxysmal Nocturnal Hemoglobinuria
StudychairStart date: 2019-06-13
NCT04679103Phase 3Completed
A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation)
Paroxysmal Nocturnal Hemoglobinuria
StudychairStart date: 2018-05-03

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04667039Phase 3StudyChair

Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis®

Age Related Macular Degeneration (ARMD)
Unknown
NCT04671810StudyChair

Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria®

Paroxysmal Nocturnal Hemoglobinuria
Completed
NCT04679103Phase 3StudyChair

A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation)

Paroxysmal Nocturnal Hemoglobinuria
Completed

All 3 trials loaded